Novartis' spending on research and development by segment 2017-2023

Published by
Matej Mikulic,
May 22, 2024
This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2023, by business segment. In 2023, the company spent the highest amount within the given period, around 11.4 billion U.S. dollars, for research and development in the brand pharmaceuticals division.

Novartis AG's spending on research and development by segment from 2017 to 2023 (in billion U.S. dollars)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2024

Region

Worldwide

Survey time period

2017 to 2023

Supplementary notes

All figures are rounded.
* During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's R&D expenses are not included from this year onwards.
** Due to the spin-off of Sandoz during 2023, there was no distribution of R&D spending by segment. The Innovative Medicines segment is now renamed to "Promoted brands".

Open this statistic in...
French
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market worldwide

Overview

5

Segments

7

Companies

8

R&D, patents, new products

8

Outlook

7

Focus: COVID-19 response

6

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

NovartisGlobal pharmaceutical industryPharmaceutical industry in the U.S.Pfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu